Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from China Bozza Development Holdings Limited ( (HK:1069) ).
China Health Technology Group Holding Company Limited has announced significant changes to its board of directors. Ms. Bu Xue has been re-designated from an independent non-executive director to an executive director, effective April 1, 2025. Ms. Bu brings over a decade of experience in marketing and business development to her new role. Additionally, Ms. Liu Shuhua has been appointed as an independent non-executive director and will join several board committees. Ms. Liu has a strong background in legal professional services and business management, having served as a legal and investment adviser for various enterprises. These changes are expected to enhance the company’s governance and strategic direction.
More about China Bozza Development Holdings Limited
YTD Price Performance: 45.00%
Average Trading Volume: 2,360,806
Technical Sentiment Signal: Hold
Current Market Cap: HK$50.7M
Find detailed analytics on 1069 stock on TipRanks’ Stock Analysis page.